Global Urological Cancer Drugs Market Size, Status and Forecast 2019-2025

Table of Contents

1 Urological Cancer Drugs Market Overview

• 1.1 Product Overview and Scope of Urological Cancer Drugs
• 1.2 Urological Cancer Drugs Segment by Type
  • 1.2.1 Global Urological Cancer Drugs Sales Growth Rate Comparison by Type (2021-2026)
  • 1.2.2 Tablets
  • 1.2.3 Injection
• 1.3 Urological Cancer Drugs Segment by Application
  • 1.3.1 Urological Cancer Drugs Sales Comparison by Application: 2020 VS 2026
  • 1.3.2 Prostate Cancer
  • 1.3.3 Bladder Cancer
  • 1.3.4 Kidney Cancer
  • 1.3.5 Testicular Cancer
  • 1.3.6 Other
• 1.4 Global Urological Cancer Drugs Market Size Estimates and Forecasts
  • 1.4.1 Global Urological Cancer Drugs Revenue 2015-2026
  • 1.4.2 Global Urological Cancer Drugs Sales 2015-2026
  • 1.4.3 Urological Cancer Drugs Market Size by Region: 2020 Versus 2026

2 Global Urological Cancer Drugs Market Competition by Manufacturers

• 2.1 Global Urological Cancer Drugs Sales Market Share by Manufacturers (2015-2020)
• 2.2 Global Urological Cancer Drugs Revenue Share by Manufacturers (2015-2020)
• 2.3 Global Urological Cancer Drugs Average Price by Manufacturers (2015-2020)
• 2.4 Manufacturers Urological Cancer Drugs Manufacturing Sites, Area Served, Product Type
• 2.5 Urological Cancer Drugs Market Competitive Situation and Trends
  • 2.5.1 Urological Cancer Drugs Market Concentration Rate
  • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
• 2.7 Primary Interviews with Key Urological Cancer Drugs Players (Opinion Leaders)

3 Urological Cancer Drugs Retrospective Market Scenario by Region

• 3.1 Global Urological Cancer Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
• 3.2 Global Urological Cancer Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
• 3.3 North America Urological Cancer Drugs Market Facts & Figures by Country
  • 3.3.1 North America Urological Cancer Drugs Sales by Country
  • 3.3.2 North America Urological Cancer Drugs Sales by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Urological Cancer Drugs Market Facts & Figures by Country
  • 3.4.1 Europe Urological Cancer Drugs Sales by Country
  • 3.4.2 Europe Urological Cancer Drugs Sales by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Urological Cancer Drugs Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Urological Cancer Drugs Sales by Region
  • 3.5.2 Asia Pacific Urological Cancer Drugs Sales by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Urological Cancer Drugs Market Facts & Figures by Country
  • 3.6.1 Latin America Urological Cancer Drugs Sales by Country
  • 3.6.2 Latin America Urological Cancer Drugs Sales by Country
  • 3.6.3 Mexico
  • 3.6.3 Brazil
  • 3.6.3 Argentina
• 3.7 Middle East and Africa Urological Cancer Drugs Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Urological Cancer Drugs Sales by Country
  • 3.7.2 Middle East and Africa Urological Cancer Drugs Sales by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Urological Cancer Drugs Historic Market Analysis by Type

• 4.1 Global Urological Cancer Drugs Sales Market Share by Type (2015-2020)
• 4.2 Global Urological Cancer Drugs Revenue Market Share by Type (2015-2020)
• 4.3 Global Urological Cancer Drugs Price Market Share by Type (2015-2020)
• 4.4 Global Urological Cancer Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Urological Cancer Drugs Historic Market Analysis by Application

• 5.1 Global Urological Cancer Drugs Sales Market Share by Application (2015-2020)
• 5.2 Global Urological Cancer Drugs Revenue Market Share by Application (2015-2020)
• 5.3 Global Urological Cancer Drugs Price by Application (2015-2020)

6 Company Profiles and Key Figures in Urological Cancer Drugs Business

• 6.1 Novartis
  • 6.1.1 Corporation Information
  • 6.1.2 Novartis Description, Business Overview and Total Revenue
  • 6.1.3 Novartis Urological Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.1.4 Novartis Products Offered
  • 6.1.5 Novartis Recent Development
• 6.2 Pfizer
  • 6.2.1 Pfizer Urological Cancer Drugs Production Sites and Area Served
  • 6.2.2 Pfizer Description, Business Overview and Total Revenue
  • 6.2.3 Pfizer Urological Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.2.4 Pfizer Products Offered
  • 6.2.5 Pfizer Recent Development
• 6.3 Johnson & Johnson
  • 6.3.1 Johnson & Johnson Urological Cancer Drugs Production Sites and Area Served
  • 6.3.2 Johnson & Johnson Description, Business Overview and Total Revenue
  • 6.3.3 Johnson & Johnson Urological Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.3.4 Johnson & Johnson Products Offered
  • 6.3.5 Johnson & Johnson Recent Development
• 6.4 AstraZeneca
  • 6.4.1 AstraZeneca Urological Cancer Drugs Production Sites and Area Served
  • 6.4.2 AstraZeneca Description, Business Overview and Total Revenue
  • 6.4.3 AstraZeneca Urological Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 AstraZeneca Products Offered
  • 6.4.5 AstraZeneca Recent Development
• 6.5 Astellas
  • 6.5.1 Astellas Urological Cancer Drugs Production Sites and Area Served
  • 6.5.2 Astellas Description, Business Overview and Total Revenue
  • 6.5.3 Astellas Urological Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.5.4 Astellas Products Offered
  • 6.5.5 Astellas Recent Development
• 6.6 Bristol-Myers Squibb
  • 6.6.1 Bristol-Myers Squibb Urological Cancer Drugs Production Sites and Area Served
  • 6.6.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
  • 6.6.3 Bristol-Myers Squibb Urological Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.6.4 Bristol-Myers Squibb Products Offered
  • 6.6.5 Bristol-Myers Squibb Recent Development
• 6.7 Abbott Laboratories
  • 6.6.1 Abbott Laboratories Urological Cancer Drugs Production Sites and Area Served
  • 6.6.2 Abbott Laboratories Description, Business Overview and Total Revenue
  • 6.6.3 Abbott Laboratories Urological Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Abbott Laboratories Products Offered
  • 6.7.5 Abbott Laboratories Recent Development
• 6.8 Celgene Corporation
  • 6.8.1 Celgene Corporation Urological Cancer Drugs Production Sites and Area Served
  • 6.8.2 Celgene Corporation Description, Business Overview and Total Revenue
  • 6.8.3 Celgene Corporation Urological Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.8.4 Celgene Corporation Products Offered
  • 6.8.5 Celgene Corporation Recent Development
• 6.9 Dendreon Corporation
  • 6.9.1 Dendreon Corporation Urological Cancer Drugs Production Sites and Area Served
  • 6.9.2 Dendreon Corporation Description, Business Overview and Total Revenue
  • 6.9.3 Dendreon Corporation Urological Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.9.4 Dendreon Corporation Products Offered
  • 6.9.5 Dendreon Corporation Recent Development
• 6.10 Ferring Pharmaceuticals
  • 6.10.1 Ferring Pharmaceuticals Urological Cancer Drugs Production Sites and Area Served
  • 6.10.2 Ferring Pharmaceuticals Description, Business Overview and Total Revenue
  • 6.10.3 Ferring Pharmaceuticals Urological Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.10.4 Ferring Pharmaceuticals Products Offered
  • 6.10.5 Ferring Pharmaceuticals Recent Development
• 6.11 GlaxoSmithKline
  • 6.11.1 GlaxoSmithKline Urological Cancer Drugs Production Sites and Area Served
  • 6.11.2 GlaxoSmithKline Urological Cancer Drugs Description, Business Overview and Total Revenue
  • 6.11.3 GlaxoSmithKline Urological Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.11.4 GlaxoSmithKline Products Offered
  • 6.11.5 GlaxoSmithKline Recent Development
• 6.12 Indevus Pharmaceuticals Inc
  • 6.12.1 Indevus Pharmaceuticals Inc Urological Cancer Drugs Production Sites and Area Served
  • 6.12.2 Indevus Pharmaceuticals Inc Urological Cancer Drugs Description, Business Overview and Total Revenue
  • 6.12.3 Indevus Pharmaceuticals Inc Urological Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.12.4 Indevus Pharmaceuticals Inc Products Offered
  • 6.12.5 Indevus Pharmaceuticals Inc Recent Development
• 6.13 Ipsen
  • 6.13.1 Ipsen Urological Cancer Drugs Production Sites and Area Served
  • 6.13.2 Ipsen Urological Cancer Drugs Description, Business Overview and Total Revenue
  • 6.13.3 Ipsen Urological Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.13.4 Ipsen Products Offered
  • 6.13.5 Ipsen Recent Development
• 6.14 Roche Healthcare
  • 6.14.1 Roche Healthcare Urological Cancer Drugs Production Sites and Area Served
  • 6.14.2 Roche Healthcare Urological Cancer Drugs Description, Business Overview and Total Revenue
  • 6.14.3 Roche Healthcare Urological Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.14.4 Roche Healthcare Products Offered
  • 6.14.5 Roche Healthcare Recent Development
• 6.15 Sanofi S.A
  • 6.15.1 Sanofi S.A Urological Cancer Drugs Production Sites and Area Served
  • 6.15.2 Sanofi S.A Urological Cancer Drugs Description, Business Overview and Total Revenue
  • 6.15.3 Sanofi S.A Urological Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.15.4 Sanofi S.A Products Offered
  • 6.15.5 Sanofi S.A Recent Development
• 6.16 Tolmar Inc
  • 6.16.1 Tolmar Inc Urological Cancer Drugs Production Sites and Area Served
  • 6.16.2 Tolmar Inc Urological Cancer Drugs Description, Business Overview and Total Revenue
  • 6.16.3 Tolmar Inc Urological Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.16.4 Tolmar Inc Products Offered
  • 6.16.5 Tolmar Inc Recent Development

7 Urological Cancer Drugs Manufacturing Cost Analysis

• 7.1 Urological Cancer Drugs Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Raw Materials Price Trend
  • 7.1.3 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Urological Cancer Drugs
• 7.4 Urological Cancer Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Urological Cancer Drugs Distributors List
• 8.3 Urological Cancer Drugs Customers

9 Market Dynamics

• 9.1 Market Trends
• 9.2 Opportunities and Drivers
• 9.3 Challenges
• 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

• 10.1 Global Urological Cancer Drugs Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Urological Cancer Drugs by Type (2021-2026)
  • 10.1.2 Global Forecasted Revenue of Urological Cancer Drugs by Type (2021-2026)
• 10.2 Urological Cancer Drugs Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Urological Cancer Drugs by Application (2021-2026)
  • 10.2.2 Global Forecasted Revenue of Urological Cancer Drugs by Application (2021-2026)
• 10.3 Urological Cancer Drugs Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Urological Cancer Drugs by Region (2021-2026)
  • 10.3.2 Global Forecasted Revenue of Urological Cancer Drugs by Region (2021-2026)
• 10.4 North America Urological Cancer Drugs Estimates and Projections (2021-2026)
• 10.5 Europe Urological Cancer Drugs Estimates and Projections (2021-2026)
• 10.6 Asia Pacific Urological Cancer Drugs Estimates and Projections (2021-2026)
• 10.7 Latin America Urological Cancer Drugs Estimates and Projections (2021-2026)
• 10.8 Middle East and Africa Urological Cancer Drugs Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List